EpiPen shortage drags on

No need for alarm as pharmacies can access limited stock
snail dragging a rock

The EpiPen 300mcg autoinjector shortage will roll on until late February.

Mylan has alerted the TGA and allergy specialists that the return to normal stock levels has been delayed by around a week.

Pharmacies will still be able to access one in-date pen for patients who return an expired device during this time.

But patients should be advised that devices with a February expiration don’t expire until the end of the month, advises the Australasian Society of Clinical Immunology and Allergy.

While using an expired pen is not ideal, research suggests recently expired pens remain potent. Therefore, if no other autoinjector is available, patients should use an expired pen, the society says.

Supply of EpiPen 150mcg is not affected by the continuing shortage.

Pharmacists should contact Mylan on 1800 274 276 to access the emergency supply.